MF-DH-300
MF-DH-300 is a 15-PGDH inhibitor with an IC50 of 1.6 nM. MF-DH-300 blocks binding of 15-PGDH to PGE2 and increases stem cell proliferation and muscle force, as well as improves mitochondrial function. MF-DH-300 increases survival motor neuron (SMN) protein expression. MF-DH-300 can be used for muscle disorders like spinal muscular atrophy (SMA) research[1].
Product Specifications
CAS Number
2673403-86-4
UNSPSC
12352100
Target
15-PGDH
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Concentration
10mM
Purity
99.53
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
N#CC1=CC=CC(N2C=CC3=C2N=CC(C(N4CCCCC4)=O)=C3)=C1
Molecular Formula
C20H18N4O
Molecular Weight
330.38
References & Citations
[1]WEBSTER M, et al. Methods for combination treatment of spinal muscular atrophy. WO2025019367A1. 2025-01-23.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human Calcium Sensing Receptor Auto Antibody (CaSR) ELISA KIT
2-chloro-N-[3- (6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl) phenyl]acetamide
